85PMechanistic Divergence of Immune Checkpoint Inhibition by an Ex Vivo Platform Derived From Patient Tumors Where Tumor and Immune Microenvironment Is Preserved
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx711.066
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2017
Authors
Publisher
Elsevier BV